← Leaderboards
Steven J. Katz
University Of Michigan At Ann Arbor
$12,985,075
Attributed
$18,828,516
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,201,360 · 11
By mechanism
P01$14,825,083 · 2
R01$12,530,759 · 5
U01$3,675,207 · 1
K05$624,983 · 1
P30$371,515 · 1
R21$173,813 · 1
Top collaborators
- Allison W. Kurian11 shared
- Lawrence Chin-I An5 shared
- Jennifer J Griggs4 shared
- Sarah T Hawley3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Cynthia L Marcelo$3,263,446
- Allison W. Kurian$2,963,883
- Reshma Jagsi$6,831,946
- Lawrence B. Holzman$27,704,361
- Xihong Lin$29,087,949
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMalignant Breast NeoplasmProgramsWomanDiagnosisDecision MakingCancer CareCancer PatientReportingOncologyBaseCaringPopulation BasedEvaluationCommunicationAffectQuality Of CareOutcomes ResearchAreaSurveysDesignPopulation SciencesMissionScreening For Cancer
Grant awards (54)
Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study$654,143
R01 · FY2025 · CA
Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study$708,444
R01 · FY2024 · CA
A population-based virtual solution to reduce gaps in genetic risk evaluation and management in families at high risk for hereditary cancer syndromes: The Georgia-California GeneLINK Trial$631,997
U01 · FY2024 · CA · contact PI
A population-based virtual solution to reduce gaps in genetic risk evaluation and management in families at high risk for hereditary cancer syndromes: The Georgia-California GeneLINK Trial$742,946
U01 · FY2023 · CA · contact PI
A population-based virtual solution to reduce gaps in genetic risk evaluation and management in families at high risk for hereditary cancer syndromes: The Georgia-California GeneLINK Trial$750,931
U01 · FY2022 · CA · contact PI
Health Behavior & Outcomes (HBO) Program$67,505
P30 · FY2022 · CA · contact PI
A population-based virtual solution to reduce gaps in genetic risk evaluation and management in families at high risk for hereditary cancer syndromes: The Georgia-California GeneLINK Trial$752,888
U01 · FY2021 · CA · contact PI
Genetic testing, treatment use, and mortality after diagnosis of breast and ovarian cancer: The Georgia-California GeneLINK Initiative$247,753
R01 · FY2021 · CA
Health Behavior & Outcomes (HBO) Program$68,762
P30 · FY2021 · CA · contact PI
A population-based virtual solution to reduce gaps in genetic risk evaluation and management in families at high risk for hereditary cancer syndromes: The Georgia-California GeneLINK Trial$796,445
U01 · FY2020 · CA · contact PI
Genetic testing, treatment use, and mortality after diagnosis of breast and ovarian cancer: The Georgia-California GeneLINK Initiative$433,498
R01 · FY2020 · CA
Health Behavior & Outcomes (HBO) Program$68,762
P30 · FY2020 · CA · contact PI
Genetic testing, treatment use, and mortality after diagnosis of breast and ovarian cancer: The Georgia-California GeneLINK Initiative$400,626
R01 · FY2019 · CA
Health Behavior & Outcomes (HBO) Program$68,760
P30 · FY2019 · CA · contact PI
Genetic testing, treatment use, and mortality after diagnosis of breast and ovarian cancer: The Georgia-California GeneLINK Initiative$480,620
R01 · FY2018 · CA
Health Behavior & Outcomes (HBO) Program$68,725
P30 · FY2018 · CA · contact PI
Health Behavior & Outcomes (HBO) Program$9,970
P30 · FY2018 · CA · contact PI
Health Behavior & Outcomes (HBO) Program$8,971
P30 · FY2018 · CA · contact PI
Health Behavior & Outcomes (HBO) Program$7,661
P30 · FY2018 · CA · contact PI
Health Behavior & Outcomes (HBO) Program$2,399
P30 · FY2018 · CA · contact PI
The Challenge of Individualizing Treatments for Patients with Breast Cancer$2,206,197
P01 · FY2016 · CA · contact PI
Administrative Core$293,533
P01 · FY2016 · CA · contact PI
The Challenge of Individualizing Treatments for Patients with Breast Cancer$2,543,942
P01 · FY2015 · CA · contact PI
Administrative Core$293,603
P01 · FY2015 · CA · contact PI
The Challenge of Individualizing Treatments for Patients with Breast Cancer$2,914,665
P01 · FY2014 · CA · contact PI
Administrative Core$285,397
P01 · FY2014 · CA · contact PI
The Challenge of Individualizing Treatments for Patients with Breast Cancer$2,764,196
P01 · FY2013 · CA · contact PI
Racial/Ethnic and SES Disparities in Quality of Breast Cancer Systemic Therapy$554,443
R01 · FY2013 · CA
Administrative Core$276,770
P01 · FY2013 · CA · contact PI
The Challenge of Individualizing Treatments for Patients with Breast Cancer$2,943,844
P01 · FY2012 · CA · contact PI
Racial/Ethnic and SES Disparities in Quality of Breast Cancer Systemic Therapy$616,385
R01 · FY2012 · CA
Administrative Core$302,936
P01 · FY2012 · CA · contact PI
Quality of Cancer Care Evaluation and Interventions$107,978
K05 · FY2011 · CA · contact PI
Racial/Ethnic and SES Disparities in Quality of Breast Cancer Systemic Therapy$637,278
R01 · FY2010 · CA
Racial/Ethnic Disparities In Work and Qol Outcomes In Survivors of Breast Cancer$499,382
R01 · FY2010 · CA · contact PI
Quality of Cancer Care Evaluation and Interventions$105,620
K05 · FY2010 · CA · contact PI
Racial/Ethnic and SES Disparities in Quality of Breast Cancer Systemic Therapy$560,091
R01 · FY2009 · CA
Racial/Ethnic Disparities In Work and Qol Outcomes In Survivors of Breast Cancer$454,206
R01 · FY2009 · CA · contact PI
Health System Factors and Patient Outcomes in Breast Cancer$354,113
R01 · FY2009 · CA · contact PI
Understanding Decision-Making in Breast Cancer Reconstruction$173,813
R21 · FY2009 · CA · contact PI
Quality of Cancer Care Evaluation and Interventions$108,000
K05 · FY2009 · CA · contact PI
Quality of Cancer Care Evaluation and Interventions$103,330
K05 · FY2009 · CA · contact PI
Health System Factors and Patient Outcomes in Breast Cancer$581,353
R01 · FY2008 · CA · contact PI
Racial/Ethnic Disparities In Work and Qol Outcomes In Survivors of Breast Cancer$539,738
R01 · FY2008 · CA · contact PI
Health System Factors and Patient Outcomes in Breast Cancer$858,666
R01 · FY2007 · CA · contact PI
Quality of Cancer Care Evaluation and Interventions$101,106
K05 · FY2007 · CA · contact PI
Health System Factors and Patient Outcomes in Breast Cancer$552,139
R01 · FY2006 · CA · contact PI
Breast Cancer Treatment Decisions & Outcomes in Latinas$446,825
R01 · FY2006 · CA · contact PI
Quality of Cancer Care Evaluation and Interventions$98,949
K05 · FY2006 · CA · contact PI
Breast Cancer Treatment Decisions &Outcomes in Latinas$547,485
R01 · FY2005 · CA
Breast Cancer Treatment Decisions &Outcomes in Latinas$479,460
R01 · FY2004 · CA
Surgical Treament for Early State Breast Cancer$495,360
R01 · FY2003 · CA
Surgical Treament for Early State Breast Cancer$727,455
R01 · FY2002 · CA
Surgical Treament for Early State Breast Cancer$701,296
R01 · FY2001 · CA